NCT01144481View on ClinicalTrials.gov

Risk Factors for Skeletal Related Events in Breast Cancer Patients Receiving Bisphosphonates for Bone Metastases

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Bone MetastasesBreast Cancer
Trial Locations (1)

M5G 2C4

University Health Network, Toronto

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University Health Network, Toronto

OTHER